Stay updated on INCAGN01876 Combo Immune Therapies Clinical Trial
Sign up to get notified when there's something new on the INCAGN01876 Combo Immune Therapies Clinical Trial page.

Latest updates to the INCAGN01876 Combo Immune Therapies Clinical Trial page
- Check2 days agoChange DetectedRevision: v3.3.4 now appears on the page in place of Revision: v3.3.3. This is a minor administrative update with no impact on study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check24 days agoChange DetectedLocations section updated to expand participating sites across the US and Australia, including Chevigny and multiple state/territory entries. The update is labeled as Revision: v3.3.3.SummaryDifference1%

- Check45 days agoChange DetectedOnly the revision label in the page footer changed from v3.3.1 to v3.3.2; no study details, eligibility criteria, or results were altered.SummaryDifference0.0%

- Check52 days agoChange DetectedFooter Revision updated from v3.2.0 to v3.3.1. No changes to study data, eligibility criteria, or listed locations.SummaryDifference0.0%

- Check60 days agoChange DetectedThe funding outage notice was removed from the page, a non-significant change that does not affect study details; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check74 days agoChange DetectedThe page now includes updated study results and outcome measures across phases, including ORR, DOR, PFS, and OS. Safety data and related study documents are also provided.SummaryDifference0.2%

Stay in the know with updates to INCAGN01876 Combo Immune Therapies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INCAGN01876 Combo Immune Therapies Clinical Trial page.